Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2012

Nov 29, 2012

33510_dirs_2012-11-29_64b48c9f-5386-4885-a897-1466acbb33e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2012-11-28

Reporting Person: LAVOY THOMAS C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-28 Common Stock P 18100 $0.49 Acquired 83523 Direct